ANDROGENETIC ALOPECIA

This study tests whether a special shampoo regimen can improve scalp health and reduce dandruff in 120 Chinese men who have had hair transplants. Some participants have mild-to-moderate seborrheic dermatitis (a common dandruff condition). The test group uses a special shampoo plu…

This pilot study tests a 1470nm laser on 10 adults with androgenetic alopecia (common baldness) or scarring alopecia. Researchers will measure hair density and counts using imaging, and track satisfaction. The goal is to see if the laser is safe and can improve hair growth.

This study tests a new treatment called EPI-001 for androgenetic alopecia (common baldness). EPI-001 is made from a patient's own scalp cells and injected into the scalp. The trial has two parts: first, finding the safest dose in a small group, then comparing the best dose to a p…

This phase 3 trial tests whether a daily 1 mg minoxidil pill can treat female pattern hair loss as effectively as the standard topical minoxidil solution. About 520 women with hair thinning will be randomly assigned to receive either the oral pill, the topical solution, or a plac…

This study tests if a once-daily 5% minoxidil foam can help women with androgenetic alopecia (female pattern hair loss) grow more hair. About 294 women aged 18 and older with mild to moderate hair loss will use either the foam or a placebo for 24 weeks. The main goal is to see if…

This study tests whether injections of secretome (a substance made by stem cells) or platelet-rich plasma (PRP) can improve hair density and thickness in people with androgenetic alopecia (common baldness). Forty men and women with mild to moderate hair loss will receive injectio…

This Phase 3 trial tests a new hair lotion called Finlândia for male pattern baldness. About 190 men aged 18-60 with moderate hair loss will use the lotion or a standard treatment for 6 months. The main goal is to see if it increases hair density on the scalp.

This study tests an oral drug called VDPHL01 in 552 women aged 18–65 with mild to moderate hereditary hair loss. Participants take a pill once or twice daily for about 13 months. The goal is to see if it increases hair count and if women feel their hair looks better. It's a place…

This study will measure a protein called JAK2 in the scalps of 25 people with male pattern baldness. Researchers will compare JAK2 levels in balding and non-balding areas, then see if 12 weeks of topical minoxidil 5% changes JAK2 in the balding scalp. The goal is to understand wh…